Sample size calculations based on day-to-day variability of stress biomarkers in persons with dementia and their family caregivers
Introduction: Accurate estimates of intra-individual variability are necessary for proper design of clinical trials and epidemiological studies where the stress biomarkers cortisol and dehydroepiandrosterone sulfate (DHEA-S) are measured for dyads of persons with dementia (PWDs) and their family car...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tabriz: Hamid Allahverdipour, 2024-
2024-11-01
|
| Series: | BioSocial Health Journal |
| Subjects: | |
| Online Access: | https://biosocialhealthjournal.com/PDF/bshj-1-146.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832086696754151424 |
|---|---|
| author | Azita Emami Jeehye Jun Gabriella Engström Lars Berglund Töres Theorell |
| author_facet | Azita Emami Jeehye Jun Gabriella Engström Lars Berglund Töres Theorell |
| author_sort | Azita Emami |
| collection | DOAJ |
| description | Introduction: Accurate estimates of intra-individual variability are necessary for proper design of clinical trials and epidemiological studies where the stress biomarkers cortisol and dehydroepiandrosterone sulfate (DHEA-S) are measured for dyads of persons with dementia (PWDs) and their family caregivers (FCGs). The aim is to determine the number of consecutive sampling days required to detect effect differences in clinical trials, and to accurately estimate regression coefficients in epidemiological studies where stress biomarkers are exposure variables in regression models with future disease as outcome. Methods: Clinical trial data from dyads of PWDs and their FCGs were used. Salivary cortisol and DHEA-S samples were collected five days a week, for eight consecutive weeks. From this data, we created formulas and graphical tools for the number of required sampling days needed to detect effect differences, and we calculated number of days needed for regression coefficients to be estimated with<10% bias. Results: A total of 5791 salivary samples from 34 dyads were used. For morning cortisol, five consecutive sampling days at baseline and an equal number of days at study termination is sufficient to detect a treatment difference>5% of baseline level with>20 dyads per group. When stress biomarkers are used in epidemiological studies at least six consecutive sampling days are required. Conclusion: Based on a large number of consecutive measurements of stress biomarkers we calculated the sufficient numbers of sampling days for clinical trials and for epidemiological studies to produce credible results. Our findings will aid researchers in the study design phase. |
| format | Article |
| id | doaj-art-f1f170589cdc45c9bf4afc6ef4f85d3d |
| institution | Kabale University |
| issn | 3060-6268 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Tabriz: Hamid Allahverdipour, 2024- |
| record_format | Article |
| series | BioSocial Health Journal |
| spelling | doaj-art-f1f170589cdc45c9bf4afc6ef4f85d3d2025-02-06T10:34:49ZengTabriz: Hamid Allahverdipour, 2024-BioSocial Health Journal3060-62682024-11-011314615310.34172/bshj.29bshj-29Sample size calculations based on day-to-day variability of stress biomarkers in persons with dementia and their family caregiversAzita Emami0Jeehye Jun1Gabriella Engström2Lars Berglund3Töres Theorell4Yale School of Nursing, Yale University, PO Box 27399, West Haven, CT, 06516 USARed Cross College of Nursing, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul, Republic of KoreaFlorida Atlantic University, Charles E. Schmidt College of Medicine, 777 Glades Road, Boca Raton, Florida, 33431 USADepartment of Public Health and Caring Sciences, Geriatrics, Uppsala University, Box 564, 751 22 Uppsala, SwedenStress Research Institute, Department of Psychology, Stockholm University, Frescativägen 8, 106 91 Stockholm, SwedenIntroduction: Accurate estimates of intra-individual variability are necessary for proper design of clinical trials and epidemiological studies where the stress biomarkers cortisol and dehydroepiandrosterone sulfate (DHEA-S) are measured for dyads of persons with dementia (PWDs) and their family caregivers (FCGs). The aim is to determine the number of consecutive sampling days required to detect effect differences in clinical trials, and to accurately estimate regression coefficients in epidemiological studies where stress biomarkers are exposure variables in regression models with future disease as outcome. Methods: Clinical trial data from dyads of PWDs and their FCGs were used. Salivary cortisol and DHEA-S samples were collected five days a week, for eight consecutive weeks. From this data, we created formulas and graphical tools for the number of required sampling days needed to detect effect differences, and we calculated number of days needed for regression coefficients to be estimated with<10% bias. Results: A total of 5791 salivary samples from 34 dyads were used. For morning cortisol, five consecutive sampling days at baseline and an equal number of days at study termination is sufficient to detect a treatment difference>5% of baseline level with>20 dyads per group. When stress biomarkers are used in epidemiological studies at least six consecutive sampling days are required. Conclusion: Based on a large number of consecutive measurements of stress biomarkers we calculated the sufficient numbers of sampling days for clinical trials and for epidemiological studies to produce credible results. Our findings will aid researchers in the study design phase.https://biosocialhealthjournal.com/PDF/bshj-1-146.pdfbiomarkerscaregiversclinical trialhydrocortisonedementiadehydroepiandrosterone sulfateepidemiologic studiessample size |
| spellingShingle | Azita Emami Jeehye Jun Gabriella Engström Lars Berglund Töres Theorell Sample size calculations based on day-to-day variability of stress biomarkers in persons with dementia and their family caregivers BioSocial Health Journal biomarkers caregivers clinical trial hydrocortisone dementia dehydroepiandrosterone sulfate epidemiologic studies sample size |
| title | Sample size calculations based on day-to-day variability of stress biomarkers in persons with dementia and their family caregivers |
| title_full | Sample size calculations based on day-to-day variability of stress biomarkers in persons with dementia and their family caregivers |
| title_fullStr | Sample size calculations based on day-to-day variability of stress biomarkers in persons with dementia and their family caregivers |
| title_full_unstemmed | Sample size calculations based on day-to-day variability of stress biomarkers in persons with dementia and their family caregivers |
| title_short | Sample size calculations based on day-to-day variability of stress biomarkers in persons with dementia and their family caregivers |
| title_sort | sample size calculations based on day to day variability of stress biomarkers in persons with dementia and their family caregivers |
| topic | biomarkers caregivers clinical trial hydrocortisone dementia dehydroepiandrosterone sulfate epidemiologic studies sample size |
| url | https://biosocialhealthjournal.com/PDF/bshj-1-146.pdf |
| work_keys_str_mv | AT azitaemami samplesizecalculationsbasedondaytodayvariabilityofstressbiomarkersinpersonswithdementiaandtheirfamilycaregivers AT jeehyejun samplesizecalculationsbasedondaytodayvariabilityofstressbiomarkersinpersonswithdementiaandtheirfamilycaregivers AT gabriellaengstrom samplesizecalculationsbasedondaytodayvariabilityofstressbiomarkersinpersonswithdementiaandtheirfamilycaregivers AT larsberglund samplesizecalculationsbasedondaytodayvariabilityofstressbiomarkersinpersonswithdementiaandtheirfamilycaregivers AT torestheorell samplesizecalculationsbasedondaytodayvariabilityofstressbiomarkersinpersonswithdementiaandtheirfamilycaregivers |